The Influence of Women's Positioning in Breast Measurements for Subsequent Breast Plastic Surgery

Bassam Ahmed ALmutlaq¹, Mohammad M. Al-Qattan², Bisher Alshanawani³, Abdullah Dakheel Alotaibi¹, Mona alkhotani³, Majid Zannon Aturkstani⁴ and Hussain Gadelkarim Ahmed^1,

¹College of Medicine, University of Hail, Kingdom of Saudi Arabia, KSA

²Plastic Surgery, Head of Research Centre, College of Medicine, King Saud University, KSA

³Consultant Plastic Surgery, Head, Plastic Club Meetings, Division of Plastic Surgery KKUH

⁴Batterjee medical college, Jeddah, KSA

Cite this paper

Bassam Ahmed ALmutlaq, Mohammad M. Al-Qattan, Bisher Alshanawani, Abdullah Dakheel Alotaibi, Mona alkhotani, Majid Zannon Aturkstani and Hussain Gadelkarim Ahmed. The Influence of Women's Positioning in Breast Measurements for Subsequent Breast Plastic Surgery. American Journal of Clinical Medicine Research. 2018; 6(1):10-14. doi: 10.12691/AJCMR-6-1-3

Abstract

Background: The confidently growing outcomes following breast plastic surgery has revealed several advantages to breast reconstructive approach, comprising precise preoperative assessment. The objective of the present study was to assess the influence of women's positioning (standing or sitting) on breast measurements. Methodology: A total of 250 women who were undergoing breast screening or breast cosmetic amendment were included. Breast measurements were performed in two positions (standing and setting). Results: All variables were significantly correlated and only left sternal notch Inframammary Fold (IMF), showed lower significant than others. Conclusion: A proper measurements can give the patients excellent cosmetic and surgery. Accurate measurement can be achieved by calculating the mean of both positioning (standing and sitting).

Keywords

breast plastic surgery, breast measurement, breast reconstruction

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Baildam AD. Oncoplastic surgery of the breast. Br J Surg 2002; 89: 532-3.
[2]	Piper M, Peled AW, Sbitany H. Oncoplastic breast surgery: current strategies. Gland Surgery. 2015; 4(2): 154-163.
[3]	Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998; 16: 2672-85.
[4]	Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; (30): 96-102.
[5]	van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001; 19: 4224-37.
[6]	Mauriac L, MacGrogan G, Avril A, et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). Ann Oncol 1999; 10: 47-52.
[7]	Mieog JS, van der Hage JA, van de Velde CJ.. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev 2007; (2): CD005002.
[8]	Chang EI, Peled AW, Foster RD, et al. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg 2012; 255: 1151-7.
[9]	Clough KB, Baruch J.. Plastic surgery and conservative treatment of breast cancer. Indications and results. Ann Chir Plast Esthet 1992; 37: 682-92.
[10]	Berry MG, Cucchiara V, Davies DM.. Breast augmentation: Part II--Adverse capsular contracture. J Plast Reconstr Aesthet Surg 2010; 63: 2098-107.
[11]	Bong J, Parker J, Clapper R, et al. Clinical series of oncoplastic mastopexy to optimize cosmesis of large-volume resections for breast conservation. Ann Surg Oncol 2010; 17: 3247-51.
[12]	Verma VP, Kaur N, Agarwal N, Bhargava SK, Singh UR, S Saha S, and Raheja A. Intra-operative measurement of tumour size in breast cancer and its comparison with other methods: a prospective study. Ecancermedicalscience 2008; 2: 96.
[13]	Jiang Y-Z, Xia C, Peng W-T, Yu KD, Zhuang ZG, Shao ZM. Preoperative Measurement of Breast Cancer Overestimates Tumor Size Compared to Pathological Measurement. PLoS ONE2014; 9(1): e86676.
[14]	Grimsby GM, Gray R, Dueck A, Carpenter S, Stucky CC, et al. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging? Am J Surg2009; 198: 500-504.
[15]	Blair S, McElroy M, Middleton MS, Comstock C, Wolfson T, et al. The efficacy of breast MRI in predicting breast conservation therapy. Journal of Surgical Oncology 2006; 94: 220-225.
[16]	Onesti JK, Mangus BE, Helmer SD, Osland JS. Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements. The American Journal of Surgery 2008; 196: 844-850.
[17]	Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat. 2008 Apr; 108(3): 333-8.
[18]	Schnabel F, Billig J, Cimeno A, Chun J. Pregnancy-associated breast cancer and increased risk of pregnancy-associated recurrence: a case report. Journal of Medical Case Reports. 2012; 6: 144.
[19]	Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status-a systematic review and meta-analysis. Annals of Oncology. 2015; 26(12): 2398-2407.
[20]	Bano R, Ismail M, Nadeem A, Khan MH, Rashid H. Potential Risk Factors for Breast Cancer in Pakistani Women. Asian Pac J Cancer Prev. 2016; 17(9): 4307-4312.
[21]	Strumylaite L, Kregzdyte R, Poskiene L, Bogusevicius A, Pranys D, Norkute R. Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women. PLoS One. 2017 Feb 2;12(2):e0171198.
[22]	Gaudet MM, Carter BD, Brinton LA, Falk RT, Gram IT, Luo J. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies. Int J Epidemiol. 2016 Dec 28. pii: dyw288.
[23]	Lee I-M, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Impact of Physical Inactivity on the World’s Major Non-Communicable Diseases. Lancet. 2012; 380(9838): 219-229.
[24]	Wengström Y, Bolam KA, Mijwel S, et al. Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy. BMC Cancer. 2017; 17: 100.
[25]	Regnault P. Breast ptosis. Definition and treatment. Clin Plast Surg. 1976 Apr; 3(2): 193-203.
[26]	Huang NS, Quan CL, Mo M, Chen JJ, Yang BL, Huang XY, Wu J. A prospective study of breast anthropomorphic measurements, volume and ptosis in 605 Asian patients with breast cancer or benign breast disease. PLoS One. 2017 Feb 13; 12(2): e0172122.